N

Minerva Neurosciences
D

NERV

1.70000
USD
0.02
(1.19%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
2
حجم السوق
11,888,790
أصول ذات صلة
A
ANVS
0.17800
(6.59%)
2.87800 USD
C
CRVS
0.06500
(1.55%)
4.25000 USD
C
CYCC
0.54000
(14.67%)
4.22000 USD
M
MGTX
0.28000
(3.35%)
8.63000 USD
NTRA
NTRA
1.581
(0.98%)
163.391 USD
X
XNCR
-0.03000
(-0.32%)
9.31000 USD
المزيد
الأخبار المقالات

العنوان: Minerva Neurosciences

القطاع: Healthcare
الصناعة: Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.